ClinicalTrials.gov
ClinicalTrials.gov Menu

Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00126620
Recruitment Status : Completed
First Posted : August 4, 2005
Last Update Posted : July 23, 2015
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University Health Network, Toronto